Wednesday, December 4, 2024

Clint Eastwood’s “Juror Number 2” Has Made Almost $10 Mil Abroad, MIA in the US

Share

Clint Eastwood’s possible final movie is a hit everywhere around the world. Except here.

International sales come to $9.6 million. This is in places like France, the UK, and Spain. There, the Eastwood film was given a decent release.

In the US, “Juror Number 2” barely exists. It’s playing in about 30 theaters, and none near you. Warner Bros. has refused to post numbers, so no one knows what it’s made. Eventually it will hit MAX streaming, and then forgotten about.

What a travesty: Warner’s has nothing else for the Oscars. “Joker Folie a Deux” imploded. “Beetlejuice Beetlejuice” is a hit, but it’s not Oscar material. “Juror Number 2” should be their prestige release. It’s a scintillating thriller with top notch work from Nicholas Hoult and Toni Collette. The screenplay is excellent. And the direction, by Eastwood, is as good as we get.

Eastwood has had countless hits for Warner Bros, and won Oscars for movies like “Unforgiven,” “Mystic River,” and “Million Dollar Baby.” He deserves better than this. And so does the audience. If it had been presented properly, “Juror Number 2” would have been a theater draw. Too bad. In this case, Warner Bros is “unforgiven.”

Roger Friedman
Roger Friedmanhttps://www.showbiz411.com
Roger Friedman began his Showbiz411 column in April 2009 after 10 years with Fox News, where he created the Fox411 column. His movie reviews are carried by Rotten Tomatoes, and he is a member of both the movie and TV branches of the Critics Choice Awards. His articles have appeared in dozens of publications over the years including New York Magazine, where he wrote the Intelligencer column in the mid 90s and covered the OJ Simpson trial, and Fox News (when it wasn't so crazy) where he covered Michael Jackson. He is also the writer and co-producer of "Only the Strong Survive," a selection of the Cannes, Sundance, and Telluride Film festivals, directed by DA Pennebaker and Chris Hegedus.

Read more

In Other News